| Literature DB >> 36128195 |
Yan-Jie Zhao1,2,3, Wei Bai1,2,3, Hong Cai1,2,3, Sha Sha4, Qinge Zhang4, Si Man Lei5, Ka-In Lok6, Ines Hang Iao Chow1,2,3, Teris Cheung7, Zhaohui Su8, Lloyd Balbuena9, Yu-Tao Xiang1,2,3.
Abstract
Background: The coronavirus disease 2019 (COVID-19) pandemic disrupted the working lives of Macau residents, possibly leading to mental health issues such as depression. The pandemic served as the context for this investigation of the network structure of depressive symptoms in a community sample. This study aimed to identify the backbone symptoms of depression and to propose an intervention target.Entities:
Keywords: COVID-19; Depression; Macao; Network analysis; Survey
Year: 2022 PMID: 36128195 PMCID: PMC9482773 DOI: 10.7717/peerj.13840
Source DB: PubMed Journal: PeerJ ISSN: 2167-8359 Impact factor: 3.061
Directed Network properties and their calculation.
| Network property | Intuitive meaning | Calculation |
|---|---|---|
| 1. Node centrality | More important nodes are central, less important nodes are peripheral | |
| a. In-(out-) strength | How well a node is directly connected to other nodes ( | |
| b. Betweenness | How often a node lies in the shortest path between pairs of nodes ( | |
| c. Closeness | How easy it is for a given node to reach other nodes without relying on intermediary nodes ( | |
| 2. Relative influence | The relative degree of incoming and outgoing edges | Positive values indicate higher outgoing strength relative to incoming strength. Negative values indicate higher incoming strength relative to outgoing strength ( |
| 3. Stability of centrality indices | How well the network structure is preserved when taking subsets of cases. | Subsamples of 70%, 60% and 50% were randomly drawn from the full sample, each with 1,000 replications. The ranking of centrality indices was averaged over replications and correlated to their ranking in the full sample ( |
| 4. Invariance of centrality indices by age (28 years and below | Whether the important symptoms differ by age or gender | Separate networks were developed by age group and gender. Then, the hypothesis that the ranks of the PHQ-9 symptoms were similar between groups was tested using the paired Wilcoxon sign rank test. |
Figure 1Study procedure flow.
Centrality measures of the nine depressive symptoms (sorted in descending order of outgoing strength).
| PHQ-9 symptom | Strength | Betweenness | Closeness | ||
|---|---|---|---|---|---|
| Outgoing | Incoming | Relative influence | |||
| D4: Loss of energy | 3.05 | 2.61 | 0.08 | 12 | 4.09 |
| D8: Psychomotor problems | 2.82 | 2.60 | 0.04 | 6 | 4.14 |
| D6: Guilt feelings | 2.43 | 2.35 | 0.02 | 8 | 3.88 |
| D7: Difficulty in concentration | 2.09 | 1.95 | 0.04 | 2 | 3.55 |
| D2: Sad mood | 1.61 | 1.66 | −0.02 | 2 | 3.35 |
| D5: Appetite change | 1.48 | 1.67 | −0.06 | 0 | 3.43 |
| D1: Anhedonia | 1.22 | 1.317 | −0.04 | 0 | 3.13 |
| D3: Sleep problems | 1.06 | 1.25 | −0.08 | 0 | 3.16 |
| D9: Suicidal ideation | 0.98 | 1.324 | −0.15 | 0 | 3.20 |
Figure 2PHQ-9 symptom networks estimated by the extended Bayesian information criterion graphical lasso method (A) and the Triangulated Maximally Filtered Graph method (B).
Key: D1: Anhedonia; D2: Sad mood; D3: Sleep problems; D4: Loss of energy; D5: Appetite change; D6: Guilt feelings; D7: Difficulty in concentration; D8: Psychomotor problems; D9: Suicidal ideation. Figure 2A: Node size indicates strength centrality and edge thickness indicates weight. Figure 2B: Shaded nodes have the highest outgoing strength. Arrows indicate the direction of influence. Yellow arrows indicate strong associations.
Rank correlations of centrality indices by the case-dropping method.
| 70% subsample retained | 60% subsample retained | 50% subsample retained | |
|---|---|---|---|
| In-strength | 0.75 | 0.76 | 0.76 |
| Out-strength | 0.93 | 0.93 | 0.93 |
| Betweenness | 0.95 | 0.94 | 0.95 |
| Closeness | 0.71 | 0.71 | 0.72 |
Centrality indices of PHQ-9 symptoms by gender.
| Outgoing strength | Incoming strength | Betweenness | Closeness | |||||
|---|---|---|---|---|---|---|---|---|
| Males | Females | Males | Females | Males | Females | Males | Females | |
| D1: Anhedonia | 1.57 | 1.60 | 1.74 | 1.68 | 0 | 2 | 3.47 | 3.38 |
| D2: Sad mood | 2.58 | 1.18 | 2.42 | 1.31 | 8 | 0 | 3.97 | 3.10 |
| D3: Sleep problems | 1.17 | 1.00 | 1.26 | 1.24 | 0 | 0 | 2.93 | 3.13 |
| D4: Loss of energy | 2.53 | 3.12 | 2.35 | 2.56 | 10 | 13 | 3.90 | 4.01 |
| D5: Appetite change | 1.09 | 1.49 | 1.31 | 1.63 | 0 | 0 | 3.22 | 3.38 |
| D6: Guilt feelings | 1.74 | 2.40 | 1.66 | 2.33 | 4 | 7 | 3.49 | 3.84 |
| D7: Difficulty in concentration | 2.93 | 2.06 | 2.70 | 1.97 | 8 | 2 | 4.27 | 3.53 |
| D8: Psychomotor problems | 2.48 | 2.79 | 2.33 | 2.58 | 2 | 6 | 3.90 | 4.09 |
| D9: Suicidal ideation | 1.03 | 0.97 | 1.36 | 1.30 | 0 | 4 | 3.05 | 3.15 |
| Wilcoxon’s signed rank test | W+ = 22 | W+ = 23 | W+ = 13 | W+ = 18 | ||||
Note:
W+: the sum of positive differences between male and female scores, W−: the sum of negative differences between male and female scores.
Centrality indices of PHQ-9 symptoms by age group.
| Outgoing strength | Incoming strength | Betweenness | Closeness | |||||
|---|---|---|---|---|---|---|---|---|
| Ages 18–28 | Ages 29–68 | Ages 18–28 | Ages 29–68 | Ages 18–28 | Ages 29–68 | Ages 18–28 | Ages 29–68 | |
| D1: Anhedonia | 1.10 | 2.62 | 1.31 | 2.56 | 0 | 8 | 3.03 | 4.15 |
| D2: Sad mood | 1.82 | 3.12 | 1.93 | 2.84 | 4 | 12 | 3.44 | 4.46 |
| D3: Sleep problems | 0.98 | 1.57 | 1.22 | 1.72 | 0 | 0 | 2.93 | 3.56 |
| D4: Loss of energy | 2.70 | 2.12 | 2.05 | 2.23 | 8 | 4 | 3.43 | 3.94 |
| D5: Appetite change | 1.43 | 1.14 | 1.62 | 1.31 | 2 | 0 | 3.26 | 2.90 |
| D6: Guilt feelings | 1.38 | 2.56 | 1.56 | 2.01 | 2 | 8 | 3.22 | 3.58 |
| D7: Difficulty in concentration | 2.48 | 2.36 | 2.48 | 2.11 | 4 | 2 | 3.94 | 3.66 |
| D8: Psychomotor problems | 2.87 | 1.52 | 2.41 | 1.82 | 10 | 0 | 3.83 | 3.29 |
| D9: Suicidal ideation | 1.02 | 1.00 | 1.19 | 1.39 | 0 | 0 | 2.92 | 3.31 |
| Wilcoxon’s signed rank test | W+ = 18 | W+ = 14 | W+ = 13 | W+ = 9.5 | ||||
Note:
W+: the sum of positive differences between male and female scores, W−: the sum of negative differences between male and female scores.
Figure 3Centrality indices of PHQ-9 symptoms by gender (z-score transformed).
Figure 4Centrality indices of PHQ-9 symptoms by age group (z-score transformed).